A Comprehensive Review of the Impact of Obesity on Plasma Cell Disorders

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2021 Oct 16

PMID 34654885

Citations 19

Authors

Richa Parikh

Syed Maaz Tariq

Catherine R Marinac

Urvi A Shah

Affiliations

Soon will be listed here.

Abstract

Multiple myeloma (MM) remains an incurable plasma cell malignancy. Although little is known about the etiology of MM, several metabolic risk factors such as obesity, diabetes, poor nutrition, many of which are modifiable, have been linked to the pathogenesis of numerous neoplasms including MM. In this article, we provide a detailed summary of what is known about the impact of obesity on the pathogenesis of MM, its influence on outcomes in MM patients, and discuss potential mechanisms through which obesity is postulated to influence MM risk and prognosis. Along with advancements in treatment modalities to improve survival in MM patients, focused efforts are needed to prevent or intercept MM at its earliest stages. The consolidated findings presented in this review highlight the need for clinical trials to assess if lifestyle modifications can reduce the incidence and improve outcomes of MM in high-risk populations. Data generated from such studies can help formulate evidence-based lifestyle recommendations for the prevention and control of MM.

Citing Articles

Effect of adipose tissue on the development of multiple myeloma.

Stanislawowski M Mol Biol Rep. 2024; 52(1):74.

PMID: 39708277 DOI: 10.1007/s11033-024-10174-8.

Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes.

Grandhi N, Liu L, Wang M, Thomas T, Schoen M, Sanfilippo K JNCI Cancer Spectr. 2024; 8(6).

PMID: 39514091 PMC: 11643351. DOI: 10.1093/jncics/pkae095.

Prevalence of metabolic comorbidities and viral co-infections in monoclonal gammopathy: a retrospective analysis.

Muradashvili T, Yu M, Browning S, Bar N, Gorshein E, Parker T Leukemia. 2024; 38(10):2281-2283.

PMID: 39164408 DOI: 10.1038/s41375-024-02380-x.

Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study.

Zhang C, Zhang D, Sun W, Tang H, Tian B, Hu L Front Nutr. 2024; 11:1400116.

PMID: 38946785 PMC: 11212462. DOI: 10.3389/fnut.2024.1400116.

Adipocytes and metabolism: Contributions to multiple myeloma.

Fairfield H, Karam M, Schimelman A, Qiang Y, Reagan M J Bone Oncol. 2024; 46:100609.

PMID: 38872708 PMC: 11169464. DOI: 10.1016/j.jbo.2024.100609.

References

Kumar S, Callander N, Alsina M, Atanackovic D, Biermann J, Castillo J . NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018. J Natl Compr Canc Netw. 2018; 16(1):11-20. DOI: 10.6004/jnccn.2018.0002. View

Sung H, Siegel R, Rosenberg P, Jemal A . Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019; 4(3):e137-e147. DOI: 10.1016/S2468-2667(18)30267-6. View

Marinac C, Birmann B . Rising cancer incidence in younger adults: is obesity to blame?. Lancet Public Health. 2019; 4(3):e119-e120. DOI: 10.1016/S2468-2667(19)30017-9. View

Landgren O, Graubard B, Katzmann J, Kyle R, Ahmadizadeh I, Clark R . Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014; 28(7):1537-42. PMC: 4090286. DOI: 10.1038/leu.2014.34. View

Thordardottir M, Lindqvist E, Lund S, Costello R, Burton D, Korde N . Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv. 2018; 1(24):2186-2192. PMC: 5737120. DOI: 10.1182/bloodadvances.2017007609. View

Samanic C, Gridley G, Chow W, Lubin J, Hoover R, Fraumeni Jr J . Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2004; 15(1):35-43. DOI: 10.1023/B:CACO.0000016573.79453.ba. View

Blair C, Cerhan J, Folsom A, Ross J . Anthropometric characteristics and risk of multiple myeloma. Epidemiology. 2005; 16(5):691-4. DOI: 10.1097/01.ede.0000172135.61188.2d. View

Reeves G, Pirie K, Beral V, Green J, Spencer E, Bull D . Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335(7630):1134. PMC: 2099519. DOI: 10.1136/bmj.39367.495995.AE. View

Engeland A, Tretli S, Hansen S, Bjorge T . Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2006; 165(1):44-52. DOI: 10.1093/aje/kwj353. View

10.

Brown L, Gridley G, Pottern L, Baris D, Swanso C, Silverman D . Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control. 2001; 12(2):117-25. DOI: 10.1023/a:1008937901586. View

11.

Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View

12.

Troy J, Hartge P, Weissfeld J, Oken M, Colditz G, Mechanic L . Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol. 2010; 171(12):1270-81. PMC: 2915494. DOI: 10.1093/aje/kwq085. View

13.

Hofmann J, Moore S, Lim U, Park Y, Baris D, Hollenbeck A . Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. Am J Epidemiol. 2013; 177(8):776-86. PMC: 3668425. DOI: 10.1093/aje/kws295. View

14.

Birmann B, Andreotti G, De Roos A, Camp N, Chiu B, Spinelli J . Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomarkers Prev. 2017; 26(6):876-885. PMC: 5457306. DOI: 10.1158/1055-9965.EPI-16-0762-T. View

15.

Marinac C, Birmann B, Lee I, Rosner B, Townsend M, Giovannucci E . Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts. Br J Cancer. 2018; 118(7):1013-1019. PMC: 5931105. DOI: 10.1038/s41416-018-0010-4. View

16.

Marinac C, Suppan C, Giovannucci E, Song M, Kvaerner A, Townsend M . Elucidating Under-Studied Aspects of the Link Between Obesity and Multiple Myeloma: Weight Pattern, Body Shape Trajectory, and Body Fat Distribution. JNCI Cancer Spectr. 2019; 3(3):pkz044. PMC: 6699596. DOI: 10.1093/jncics/pkz044. View

17.

Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni Jr J . Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006; 17(7):901-9. DOI: 10.1007/s10552-006-0023-9. View

18.

Britton J, Khan A, Rohrmann S, Becker N, Linseisen J, Nieters A . Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica. 2008; 93(11):1666-77. DOI: 10.3324/haematol.13078. View

19.

Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Zendehdel K . Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res. 2007; 67(12):5983-6. DOI: 10.1158/0008-5472.CAN-07-0274. View

20.

Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T . Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2010; 19(6):1623-31. DOI: 10.1158/1055-9965.EPI-10-0171. View